Skip to main content
. 2020 Sep 10;20:445. doi: 10.1186/s12935-020-01534-y

Table 3.

Correlation of EZH2 mRNA expression with the clinicopathological factors of esophageal carcinoma patients

Clinicopathological parameters No. of patients EZH2 expression relative to β-Actin p-value
Age
 ≥ 50 40 6.53 ± 1.4 0.595
 < 50 12 6.61 ± 1.9
Sex
 Male 31 6.47 ± 1.4 0.751
 Female 21 6.66 ± 1.6
Classification
 Locally advanced resectable 25 6.59 ± 1.5
 Locally advanced unresectable 23 6.63 ± 1.6 0.532
 Metastatic 4 5.79 ± 1.1
Dysphagia Grade
 dys Gr1 1 6.34 ± 0
 dys Gr2 18 6.31 ± 1.5
 dys Gr3 21 6.96 ± 1.5 0.314
 dys Gr4 11 6.41 ± 1.2
 dys Gr5 1 3.83 ± 0
Location of Tumor
 Upper third 7 6.28 ± 1.9
 Middle third 24 6.67 ± 1.6 0.799
 Lower third 21 6.51 ± 1.2
Smoking
 Smoker 30 6.51 ± 1.3 0.803
 Non-smoker 22 6.60 ± 1.7
Alcohol
 Alcoholic 20 6.58 ± 1.6 0.94
 Non-Alcoholic 32 6.53 ± 1.5
Tobacco
 Tobacco Chewer 5 6.32 ± 1.2 0.78
 Non-Tobacco Chewer 47 6.57 ± 1.5
Type
 SCC 47 6.58 ± 1.5 0.609
 Adeno 5 6.19 ± 0.8
Diet
 Veg 28 6.33 ± 1.3 0.233
 NonVeg 24 6.80 ± 1.6